Email

Lymphokine-Activated Killer Cell

Cytolytic Lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh Tumor Cells. They are Interleukin-2-activated NK Cells that have no Major Histocompatibility Complex restriction or need for Antigen stimulation. LAK Cells are used for Adoptive Immunotherapy in cancer Patients.